BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36008233)

  • 21. Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before-after design.
    Machalek D; Rees H; Chikandiwa A; Munthali R; Travill D; Mbulawa Z; Petoumenos K; Delany-Moretlwe S; Kaldor J;
    BMJ Open; 2022 Feb; 12(2):e059968. PubMed ID: 35144959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications and efficacy of the human papillomavirus vaccine.
    Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
    Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness.
    Jit M; Prem K; Benard E; Brisson M
    Prev Med; 2021 Mar; 144():106354. PubMed ID: 33309871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives for the development of human papillomavirus vaccines and immunotherapy.
    Bermúdez-Humarán LG; Langella P
    Expert Rev Vaccines; 2010 Jan; 9(1):35-44. PubMed ID: 20021304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus and cervical cancer risk perception and vaccine acceptability among adolescent girls and young women in Durban, South Africa.
    Russell VL; Ogilvie G; Beksinska M; Nyrenda M; Mitchell-Foster S; Lavoie J; Harder H; Wood B; Smith P; Dietrich JJ; Smit J; Brockman MA; Gray G; Kaida On Behalf Of The Ayazazi Research Team A
    S Afr Med J; 2020 Aug; 110(9):887-893. PubMed ID: 32880274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
    Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
    Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.
    Luciani S; Jauregui B; Kieny C; Andrus JK
    Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs.
    Murillo R; Ordóñez-Reyes C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1317-1326. PubMed ID: 31455660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan.
    Tang CH; Cheng WF; Jiang JH; You SL; Huang LW; Hsieh JY; Mukherjee P; Van Kriekinge G; Lee C
    Asian Pac J Cancer Prev; 2019 May; 20(5):1377-1387. PubMed ID: 31127896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
    Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
    Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Papillomavirus associated prevention: knowledge, attitudes, and perceived risks among men who have sex with men and transgender women in Pakistan: a qualitative study.
    Ejaz M; Ekström AM; Ahmed A; Haroon A; Ali D; Ali TS; Salazar M
    BMC Public Health; 2022 Feb; 22(1):378. PubMed ID: 35193544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
    McIntosh J; Sturpe DA; Khanna N
    J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers.
    Aninye IO; Berry-Lawhorn JM; Blumenthal P; Felder T; Jay N; Merrill J; Messman JB; Nielsen S; Perkins R; Rowen T; Saslow D; Trimble CL; Smith-McCune K
    J Womens Health (Larchmt); 2021 Dec; 30(12):1667-1672. PubMed ID: 34871035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Papillomavirus (HPV): unawareness of the causal role of HPV infection in cervical cancer, HPV vaccine availability, and HPV vaccine uptake among female schoolteachers in a Middle Eastern country.
    Rezqalla J; Alshatti M; Ibraheem A; Omar D; Houda AF; AlHaqqan S; AlGhurair S; Akhtar S
    J Infect Public Health; 2021 May; 14(5):661-667. PubMed ID: 33857726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "I don't Think He Needs the HPV Vaccine Cause Boys Can't Have Cervical Cancer": a Qualitative Study of Latina Mothers' (Mis) Understandings About Human Papillomavirus Transmission, Associated Cancers, and the Vaccine.
    Lindsay AC; Delgado D; Valdez MJ; Restrepo E; Guzman YM
    J Cancer Educ; 2022 Apr; 37(2):370-378. PubMed ID: 32654037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.